DEFECTIVE EXPRESSION OF T-CELL CD40 LIGAND CAUSES X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM

被引:666
作者
KORTHAUER, U
GRAF, D
MAGES, HW
BRIERE, F
PADAYACHEE, M
MALCOLM, S
UGAZIO, AG
NOTARANGELO, LD
LEVINSKY, RJ
KROCZEK, RA
机构
[1] UNIV ERLANGEN NURNBERG, INST KLIN IMMUNOL, ARBEITSGRP IMMUNOL, MAX PLANCK GESELLSCH, W-8520 ERLANGEN, GERMANY
[2] SCHERING PLOUGH CORP, IMMUNOL RES LAB, F-69571 DARDILLY, FRANCE
[3] INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND
[4] UNIV BRESCIA, I-25123 BRESCIA, ITALY
关键词
D O I
10.1038/361539a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
X CHROMOSOME-LINKED immunodeficiency with hyper-IgM (HIGM1, MIM number 308230) is a rare disorder characterized by recurrent bacterial infections, very low or absent IgG, IgA and IgE, and normal to increased IgM and IgD serum levels1-3. HIGM1 has been suggested to result from ineffective T-cell help for B cells4. We and others5-8 have identified a novel, TNF-related activation protein (TRAP) that is exclusively expressed on the surface of stimulated T cells6,8. TRAP, a type II transmembrane protein of M(r) 33,000, is the physiological ligand for CD40 (refs 5-8). Crosslinking of CD40 on B cells induces, in the presence of lymphokines, immunoglobulin class switching from IgM to IgG, IgA or IgE5,9-11. Mapping of the TRAP gene to the X-chromosomal location q26.3-q27.1 (ref. 6) suggested a causal relationship to HIGM1, which had previously been assigned to Xq26 (refs 12-14). Here we present evidence that point mutations in the TRAP gene give rise to nonfunctional or defective expression of TRAP on the surface of T cells in patients with HIGM1. The resultant failure of TRAP to interact with CD40 on functionally intact B cells is responsible for the observed immunoglobulin isotype defect in HIGM1.
引用
收藏
页码:539 / 541
页数:3
相关论文
共 18 条
[1]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[2]   GROWING HUMAN LYMPHOCYTES-B IN THE CD40 SYSTEM [J].
BANCHEREAU, J ;
ROUSSET, F .
NATURE, 1991, 353 (6345) :678-679
[3]   ROLE OF POTENTIALLY CHARGED TRANSMEMBRANE RESIDUES IN TARGETING PROTEINS FOR RETENTION AND DEGRADATION WITHIN THE ENDOPLASMIC-RETICULUM [J].
BONIFACINO, JS ;
COSSON, P ;
SHAH, N ;
KLAUSNER, RD .
EMBO JOURNAL, 1991, 10 (10) :2783-2793
[4]  
BURTIN P, 1961, REV FR ETUD CLIN BIO, V6, P286
[5]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[6]   CLONING OF TRAP, A LIGAND FOR CD40 ON HUMAN T-CELLS [J].
GRAF, D ;
KORTHAUER, U ;
MAGES, HW ;
SENGER, G ;
KROCZEK, RA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) :3191-3194
[7]  
HERMANN P, IN PRESS EUR J IMMUN
[8]   THE HUMAN T-CELL ANTIGEN GP39, A MEMBER OF THE TNF GENE FAMILY, IS A LIGAND FOR THE CD40 RECEPTOR - EXPRESSION OF A SOLUBLE FORM OF GP39 WITH B-CELL COSTIMULATORY ACTIVITY [J].
HOLLENBAUGH, D ;
GROSMAIRE, LS ;
KULLAS, CD ;
CHALUPNY, NJ ;
BRAESCHANDERSEN, S ;
NOELLE, RJ ;
STAMENKOVIC, I ;
LEDBETTER, JA ;
ARUFFO, A .
EMBO JOURNAL, 1992, 11 (12) :4313-4321
[9]   CD40 AND IGE - SYNERGISM BETWEEN ANTI-CD40 MONOCLONAL-ANTIBODY AND INTERLEUKIN-4 IN THE INDUCTION OF IGE SYNTHESIS BY HIGHLY PURIFIED HUMAN B-CELLS [J].
JABARA, HH ;
FU, SM ;
GEHA, RS ;
VERCELLI, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1861-1864
[10]   MECHANISM OF ANTIGEN-DRIVEN SELECTION IN GERMINAL-CENTERS [J].
LIU, YJ ;
JOSHUA, DE ;
WILLIAMS, GT ;
SMITH, CA ;
GORDON, J ;
MACLENNAN, ICM .
NATURE, 1989, 342 (6252) :929-931